DK1239862T3 - Farmaceutisk præparat indeholdende cytostatika og eletronacceptorer til behandling af kræft - Google Patents

Farmaceutisk præparat indeholdende cytostatika og eletronacceptorer til behandling af kræft

Info

Publication number
DK1239862T3
DK1239862T3 DK00979624T DK00979624T DK1239862T3 DK 1239862 T3 DK1239862 T3 DK 1239862T3 DK 00979624 T DK00979624 T DK 00979624T DK 00979624 T DK00979624 T DK 00979624T DK 1239862 T3 DK1239862 T3 DK 1239862T3
Authority
DK
Denmark
Prior art keywords
eletron
acceptors
cancer
treatment
pharmaceutical preparation
Prior art date
Application number
DK00979624T
Other languages
English (en)
Inventor
Miklos Ghyczy
Joerg Hager
Armin Wendel
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Application granted granted Critical
Publication of DK1239862T3 publication Critical patent/DK1239862T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK00979624T 1999-12-09 2000-11-25 Farmaceutisk præparat indeholdende cytostatika og eletronacceptorer til behandling af kræft DK1239862T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19959546A DE19959546A1 (de) 1999-12-09 1999-12-09 Pharmazeutische Zubereitung zur Behandlung von Tumorerkrankungen
PCT/EP2000/011761 WO2001041747A2 (de) 1999-12-09 2000-11-25 Pharmazeutische zubeteitung enthaltend zytostatika und electronenakzeptoren zur behandlung von krebs

Publications (1)

Publication Number Publication Date
DK1239862T3 true DK1239862T3 (da) 2005-10-31

Family

ID=7932121

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00979624T DK1239862T3 (da) 1999-12-09 2000-11-25 Farmaceutisk præparat indeholdende cytostatika og eletronacceptorer til behandling af kræft

Country Status (15)

Country Link
US (2) US20010021704A1 (da)
EP (1) EP1239862B3 (da)
JP (2) JP2003516348A (da)
AR (1) AR026911A1 (da)
AT (1) ATE299025T1 (da)
AU (1) AU781943B2 (da)
CA (1) CA2393487C (da)
DE (2) DE19959546A1 (da)
DK (1) DK1239862T3 (da)
ES (1) ES2243328T7 (da)
IL (2) IL149975A0 (da)
MX (1) MXPA02005045A (da)
PT (1) PT1239862E (da)
TW (1) TWI260224B (da)
WO (1) WO2001041747A2 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007009650A1 (de) * 2007-02-26 2008-08-28 Beiersdorf Ag Kosmetisches Kombinationsprodukt zur Verbesserung des äußeren Erscheinungsbildes
KR101907411B1 (ko) 2010-03-12 2018-10-12 베르그 엘엘씨 코엔자임 Ｑ10(ＣｏＱ10)의 정맥내 제형 및 이의 사용 방법
CN107095863A (zh) 2011-06-17 2017-08-29 博格有限责任公司 可吸入药物组合物
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
PL3298021T3 (pl) 2015-05-18 2019-11-29 Tolero Pharmaceuticals Inc Proleki alvocidibu o zwiększonej biodostępności
US20190175598A1 (en) 2016-08-23 2019-06-13 Eisai R&D Management Co., Ltd. Combination therapies for the treatment of hepatocellular carcinoma
WO2018094275A1 (en) 2016-11-18 2018-05-24 Tolero Pharmaceuticals, Inc. Alvocidib prodrugs and their use as protein kinase inhibitors
BR112019019261A2 (pt) 2017-03-16 2020-06-16 Eisai R & D Management Co., Ltd. Terapias de combinação para o tratamento de câncer de mama
WO2019055579A1 (en) 2017-09-12 2019-03-21 Tolero Pharmaceuticals, Inc. TREATMENT REGIME FOR CANCERS THAT ARE INSENSITIVE TO BCL-2 INHIBITORS USING THE MCL-1 ALVOCIDIB INHIBITOR
JP2022511029A (ja) 2018-12-04 2022-01-28 スミトモ ダイニッポン ファーマ オンコロジー， インコーポレイテッド がんの処置のための薬剤としての使用のためのｃｄｋ９インヒビターおよびその多形
JP2022525149A (ja) 2019-03-20 2022-05-11 スミトモ ダイニッポン ファーマ オンコロジー， インコーポレイテッド ベネトクラクスが失敗した急性骨髄性白血病（ａｍｌ）の処置
CN117417397A (zh) * 2023-10-17 2024-01-19 浙江亚瑟医药有限公司 一种盐酸伊达比星晶型及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0617309B2 (ja) * 1985-11-29 1994-03-09 株式会社ビタミン研究所 アドリアマイシン包埋リポソ−ム製剤
US4797285A (en) * 1985-12-06 1989-01-10 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Lipsome/anthraquinone drug composition and method
IN164232B (da) * 1986-04-11 1989-02-04 Hoechst India
DE3836676A1 (de) * 1988-10-28 1990-05-03 Hoechst Ag Die verwendung von 4h-1-benzopyran-4-on-derivaten, neue 4h-1-benzopyran-4-on-derivate und diese enthaltende arzneimittel
JP3119430B2 (ja) * 1995-07-25 2000-12-18 大鵬薬品工業株式会社 水酸基ラジカル消去剤
DE19724796A1 (de) * 1997-06-06 1998-12-10 Max Delbrueck Centrum Mittel zur Antitumortherapie
PT1100589E (pt) * 1998-07-30 2005-05-31 Sigma Tau Ind Farmaceuti Utilizacao de propionil-l-carnitina e acetil-l-carnitina na preparacao de medicamentos com actividade anticancerigena
WO2000012071A2 (de) * 1998-08-29 2000-03-09 Miklos Ghyczy Pharmazeutisches und/oder diätetisches produkt
DE19843968A1 (de) * 1998-09-24 2000-04-13 Hans Dietl Taxane enthaltende pharmazeutische Zubereitung zur intravenösen Applikation und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
IL149975A0 (en) 2002-12-01
IL149975A (en) 2007-02-11
WO2001041747A2 (de) 2001-06-14
ATE299025T1 (de) 2005-07-15
JP2012162577A (ja) 2012-08-30
AU1704801A (en) 2001-06-18
EP1239862A2 (de) 2002-09-18
DE19959546A1 (de) 2001-06-21
AR026911A1 (es) 2003-03-05
PT1239862E (pt) 2005-10-31
AU781943B2 (en) 2005-06-23
CA2393487A1 (en) 2001-06-14
US20040235783A1 (en) 2004-11-25
CA2393487C (en) 2010-11-09
MXPA02005045A (es) 2003-09-25
DE50010681D1 (de) 2005-08-11
US20010021704A1 (en) 2001-09-13
ES2243328T3 (es) 2005-12-01
TWI260224B (en) 2006-08-21
EP1239862B1 (de) 2005-07-06
WO2001041747A3 (de) 2002-02-07
ES2243328T7 (es) 2012-03-16
EP1239862B3 (de) 2011-09-07
JP2003516348A (ja) 2003-05-13

Similar Documents

Publication Publication Date Title
NO20021401D0 (no) Konazolinforbindelser og farmasöytiske preparater inneholdende slike forbindelser
DK1093370T3 (da) Farmaceutisk præparat til behandling af diabetes
PT1207867E (pt) Formas de administracao farmaceuticas orais retardadas contendo tramadol
IS2468B (is) Aðferðir og milliefni til framleiðslu á efnasamböndum gegn krabbameini
DK0956858T3 (da) Farmaceutiske præparater indeholdende lactobacilli til behandling af vaginale infektioner
DK1158992T3 (da) Anvendelse af xenon til fremstilling af et farmaceutisk præparat til behandling af neurointoksikationer
EE200200357A (et) Ravimaine suurenenud kontsentratsioone andvad farmatseutilised kompositsioonid
DK0941103T3 (da) Farmaceutisk præparat til behandling af diabetes
NO20024175D0 (no) Azetidinderivater, deres fremstilling og farmasöytiske forbindelser inneholdende de samme
DK1345910T3 (da) Quinazolinderivater, lægemidler indeholdende forbindelserne, deres anvendelse og fremgangsmåde til fremstilling deraf
IS5245A (is) Lyfjablanda úr ómeprasól
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DK1202965T3 (da) Indolderivater, fremgangsmåde til fremstilling deraf, farmaceutiske præparater indeholdende disse og deres medicinske anvendelse
HUP0700039A2 (en) Use of cannabinoid drugs for the preparation of medicines for decreasing cell proliferation
PL352547A1 (en) Drugs containing inhibitors of human kinase h-sgk
NO20015516L (no) Preparater og anvendelser av ET743 for behandling av kreft
EE04418B1 (et) Moksifloksatsiini farmatseutiline preparaat
NO20020086D0 (no) Smaksmaskerte farmasöytiske flytende formuleringer
IS2223B (is) Aðferð til framleiðslu á 5-sýanóþalíði
EE05020B1 (et) Glburiidi ravimkoostis
DK0991654T3 (da) Hidtil ukendte derivater af 2-(iminomethyl)aminophenyl, deres fremstilling, deres anvendelse til medikamenter og farmaceutiske præparater indeholdende samme
NO20015542D0 (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
DK1150991T3 (da) Præparater til behandling af inflammatoriske reaktioner
NO331215B1 (no) Kit av deler og farmasoytiske formuleringer
DK1041985T3 (da) Kombination af benzocycloheptapyridinforbindelser og antineoplastiske lægemidler til behandling af profilerative sygdomme